Immune Response News and Research

RSS

Chromatin array a new technology for examining DNA

A new technique for examining DNA is giving scientists a more detailed picture of which genes have the propensity for activation, offering a new tool for understanding how genes function and possibly for diagnosing disease.

8 Jul 2004

Type of cellular stress called osmotic stress is critical to cell growth and the body’s immune response against infection

Researchers at the University of California, San Diego (UCSD) School of Medicine have determined that a particular type of cellular stress called osmotic stress is of critical importance to cell growth and the body’s immune response against infection.

7 Jul 2004

Stress alters immunity

Psychologists have long known that stress affects our ability to fight infection, but a major new “meta-analysis” – a study of studies – has elucidated intriguing patterns of how stress affects human immunity, strengthening it in the short term but wearing it down over time.

2 Jul 2004

Protein called Rac controls a number of biological processes and is directly implicated in several human diseases

Scientists at The Scripps Research Institute have described the regulatory mechanism of an important human protein called Rac that controls a number of biological processes and is directly implicated in several human diseases.

2 Jul 2004

Celiac disease may affect 3 million Americans, ten times higher than previous estimates

Celiac disease is considerably under-diagnosed, according to an independent consensus panel convened this week by the National Institutes of Health (NIH).

1 Jul 2004

Harmless form of the herpes virus may help create a vaccine for Alzheimer’s disease

Scientists have taken an important step toward creating a vaccine against Alzheimer’s disease, customizing the response of the immune system with unprecedented precision.

30 Jun 2004

12 sites testing a new vaccine to prevent anthrax

The phase II trial will evaluate the safety and immunogenic response of a new recombinant anthrax vaccine, known as rPA102. The vaccine candidate consists of recombinant Protective Antigen (rPA), a synthetic protein that induces antibodies designed to prevent illness by neutralizing anthrax toxins, and aluminum hydroxide to enhance the immune response.

29 Jun 2004

Understanding how some diseases evade our body's defense system may help explain the incomplete control of chronic viral infections by the immune system

For Keith Jerome, M.D, Ph.D., the most intriguing question about cancer is not what causes it but why our bodies fail to defend us from the disease after it strikes.

29 Jun 2004

A single dose of a test vaccine sprayed into the nose protects monkeys against the SARS virus

The study, published in the June 26 issue of the British journal The Lancet, is the third recently issued by NIAID that describes a promising candidate vaccine against SARS.

25 Jun 2004

Animal vaccine shows potential for the development of human SARS immunisation

The current issue of the LANCET provides evidence for the effectiveness of experimental SARS immunisation in animal studies. The preliminary results show the potential for the development of human SARS immunisation.

24 Jun 2004

European marketing approval for new influenza vaccine

Solvay Pharmaceuticals announced today that it has obtained European marketing approval for its new virosomal influenza vaccine: INVIVAC®.

23 Jun 2004

We want to figure out how to grow new kidneys in humans

Growing new organs to take the place of damaged or diseased ones is moving from science fiction to reality, according to researchers at Washington University School of Medicine in St. Louis.

22 Jun 2004

Findings could explain why island populations worldwide are particularly susceptible to disease

Researchers have shown that Darwin's finches on smaller islands in the Galapagos archipelago have weaker immune responses to disease and foreign pathogens---findings that could help explain why island populations worldwide are particularly susceptible to disease.

15 Jun 2004

New whole body positron emission tomography (PET) imaging allows scientists to watch as immune system respond to tumors or infection

Compared to the snapshot views of the immune system from tumor biopsies or blood assays, this whole body imaging allows scientists to track how the immune response changes, and the tumor or infection responds, throughout the different phases of immune response and over long periods of time.

15 Jun 2004

Significant vaccine advance for Parkinson’s disease therapy

Scientists at the University of Nebraska Medical Center in Omaha and Columbia University Medical Center in New York have discovered a new vaccine approach that successfully prevents the death of brain cells in a mouse model of Parkinson’s disease.

15 Jun 2004

Drug commonly used for diabetes might be effective in treating multiple sclerosis

Researchers at the University of Illinois at Chicago are launching a clinical trial to determine whether a drug commonly used for diabetes might be effective in treating multiple sclerosis, an autoimmune disease that affects 350,000 Americans.

10 Jun 2004

£20 million funding for stem cell research in the UK

Scientists at Oxford will benefit from a share of a £20 million cross-research council investment in stem cell research which was announced last month.

9 Jun 2004

Discovery could pave the way to smallpox Immunity

A team of scientists led by a Howard Hughes Medical Institute (HHMI) international research scholar has discovered the immune system mechanism that causes some mice to be more susceptible to mousepox than others.

9 Jun 2004

Breakthrough could help protect against the use of smallpox by terrorists

Researchers at the ANU John Curtin School of Medical Research have identified proteins that determine which mice succumb to mousepox and which do not. The new insights into the immune response of mice to the mousepox virus could enable scientists to improve treatment for poxvirus infections, including smallpox.

9 Jun 2004

New therapy to send cancer-killing drugs directly to tumours

Disguising a molecule to get it past the body's immune system could greatly enhance the success of a groundbreaking new therapy, Cancer Research UK scientists report in the British Journal of Cancer this week.

2 Jun 2004

Immune Response News and Research

Chromatin array a new technology for examining DNA

Type of cellular stress called osmotic stress is critical to cell growth and the body’s immune response against infection

Stress alters immunity

Protein called Rac controls a number of biological processes and is directly implicated in several human diseases

Celiac disease may affect 3 million Americans, ten times higher than previous estimates

Harmless form of the herpes virus may help create a vaccine for Alzheimer’s disease

12 sites testing a new vaccine to prevent anthrax

Understanding how some diseases evade our body's defense system may help explain the incomplete control of chronic viral infections by the immune system

A single dose of a test vaccine sprayed into the nose protects monkeys against the SARS virus

Animal vaccine shows potential for the development of human SARS immunisation

European marketing approval for new influenza vaccine

We want to figure out how to grow new kidneys in humans

Findings could explain why island populations worldwide are particularly susceptible to disease

New whole body positron emission tomography (PET) imaging allows scientists to watch as immune system respond to tumors or infection

Significant vaccine advance for Parkinson’s disease therapy

Drug commonly used for diabetes might be effective in treating multiple sclerosis

£20 million funding for stem cell research in the UK

Discovery could pave the way to smallpox Immunity

Breakthrough could help protect against the use of smallpox by terrorists

New therapy to send cancer-killing drugs directly to tumours

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News